Studies on Aim2-/- mice have shown a higher incidence of colitis-associated CRC compared to Asc-/-mice with defective inflammasomes, suggesting that AIM2's impact on CRC is not dependent on inflammasome activation. The gene discussed is AIM2; the disease is colitis.